Stabiliser for radiopharmaceuticals

Details Stabiliser for radiopharmaceuticals Stabiliser for radiopharmaceuticals

2011-03-29

2011-03-29

Jones, D. L (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C206S223000, C206S569000

Reexamination Certificate

active

07914768

ABSTRACT:
A stabilized radiopharmaceutical composition, a kit including same, and a method for making same, where the radiopharmaceutical is (i) susceptible to either reductive degradation or radiolysis and which includes a metal complex of a radionuclide with a ligand, (ii) a first stabilizer for the radiopharmaceutical which is an amino-substituted aromatic carboxylic acid or a salt, ester or amide thereof, and (iii) a second stabilizer for the radiopharmaceutical which is a diphosphonic acid or salt thereof. The first and second stabilizers are present in an amount effective to stabilize the radiopharmaceutical, and the radiopharmaceutical is not a metal complex of the diphosphonic acid.

REFERENCES:
patent: 4451451 (1984-05-01), Rimmer
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4642229 (1987-02-01), Cumming et al.
patent: 5093105 (1992-03-01), Flanagan et al.
patent: 5175343 (1992-12-01), Fritzberg et al.
patent: 0 250 966 (1988-01-01), None
patent: 0 508 724 (1992-10-01), None
patent: WO87/01289 (1987-03-01), None
S. J. Mathers, et al. “Reduction-Mediated Technetium-99M Labeling of Monoclonal Antibodies” Journal of Nuclear Medicine vol. 31, No. 5, 1990 pp. 692-697.
A. Morales, et al. “Freeze-dried formulation for the direct 99m-Tc-labeling of ior egf/r3 monoclonal antibody: Equivalence studies” Biotechnologia Aplicada vol. 17, No. 1, Jan. 1, 2000 pp. 39-44.
K. Schomacker, et al. “Verschiedene 99mTc-Generatoreluate: Auswirkungen auf die radiochemische Reinheit der Markierungsprodukte” Nuklearmedizin, Feb. 1994, vol. 33, No. 1 pp. 33-39.
B. Cleynhens, et al. “Evaluation of the efficacy of different antioxidants in technetium 99m-methylenediphosphonic acid preparations” Nuklearmedizin, Suppl., 1991, vol. 27 pp. 133-135.
D. E. Heggli, et al. “Differences in biodistribution in rats injected with 99m-Tc-MDP preparations with different stabilizing agents” European Journal of Nuclear Medicine 1988, vol. 14, No. 2 pp. 105-107.
J. Godard, et al. “Traitement de l'oedeme cerebral peritumoral par le tetracosactide” La Presse Medicale, May 15, 1993, vol. 22, No. 17 pp. 806-810.

Affiliated with

Also associated with

Rating

Stabiliser for radiopharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stabiliser for radiopharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabiliser for radiopharmaceuticals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2661112